E. Hatipoğlu Et Al. , "No evidence of increased anti-M3 muscarinic acetylcholine receptor autoantibodies in SSA-positive connective tissue disease patients," APMIS , vol.131, no.10, pp.552-555, 2023
Hatipoğlu, E. Et Al. 2023. No evidence of increased anti-M3 muscarinic acetylcholine receptor autoantibodies in SSA-positive connective tissue disease patients. APMIS , vol.131, no.10 , 552-555.
Hatipoğlu, E., Mikkelsen, J. H., Korsholm, T., Hvid, M., Deleuran, B., & Dahl, M. L. N., (2023). No evidence of increased anti-M3 muscarinic acetylcholine receptor autoantibodies in SSA-positive connective tissue disease patients. APMIS , vol.131, no.10, 552-555.
Hatipoğlu, Elif Et Al. "No evidence of increased anti-M3 muscarinic acetylcholine receptor autoantibodies in SSA-positive connective tissue disease patients," APMIS , vol.131, no.10, 552-555, 2023
Hatipoğlu, Elif Et Al. "No evidence of increased anti-M3 muscarinic acetylcholine receptor autoantibodies in SSA-positive connective tissue disease patients." APMIS , vol.131, no.10, pp.552-555, 2023
Hatipoğlu, E. Et Al. (2023) . "No evidence of increased anti-M3 muscarinic acetylcholine receptor autoantibodies in SSA-positive connective tissue disease patients." APMIS , vol.131, no.10, pp.552-555.
@article{article, author={Elif Hatipoğlu Et Al. }, title={No evidence of increased anti-M3 muscarinic acetylcholine receptor autoantibodies in SSA-positive connective tissue disease patients}, journal={APMIS}, year=2023, pages={552-555} }